Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 12:37 PM
Ignite Modification Date: 2025-12-25 @ 12:11 PM
NCT ID: NCT00750061
Description: None
Frequency Threshold: 0
Time Frame: 6 months
Study: NCT00750061
Study Brief: Efficacy and Safety of Lithium Carbonate in the Treatment of Chronic Spinal Cord Injuries
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Lithium Carbonate Tablet Lithium Carbonate: The subject start at a dosage regime of three times a day and one tablet of lithium carbonate, 250mg/table, oral administration each time for three days. The daily dose will be adjusted according to the serum lithium level and the clinical findings. Target serum lithium level is 0.6-1.2mM. The course of medication is 6 weeks. None None 0 20 16 20 View
Placebo Placebo: Matching placebo None None 0 20 14 20 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Dry eye NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (17.1) View
Nausea NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
Abdominal discomfort NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
Diarrhoea NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
Vomiting NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
Salivary hypersecretion NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
Toothache NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
Gingival swelling NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
Gastrooesophageal disease NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
Asthenia NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.1) View
Thirst NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.1) View
Pain NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.1) View
Oedema NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.1) View
Chest discomfort NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.1) View
Urogenital infection bacterial NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (17.1) View
Upper respiratory tract infection NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (17.1) View
Urine output NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (17.1) View
Blood glucose abnormal NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (17.1) View
Blood creatinine increased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (17.1) View
Alanine aminotransferase increased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (17.1) View
Urine sediment present NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (17.1) View
Aspartate aminotransferase increase NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (17.1) View
Glucose urine present NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (17.1) View
Neutrophil count decreased NON_SYSTEMATIC_ASSESSMENT Investigations MedDRA (17.1) View
Polydipsia NON_SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (17.1) View
Back pain NON_SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (17.1) View
Limb discomfort NON_SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (17.1) View
Muscle spasms NON_SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (17.1) View
Poor quality sleep NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
Headache NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
Dizziness NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
Hypoaesthesia NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
Somnolence NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
Tremor NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
Hypotonia NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
Self injurious behaviour NON_SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (17.1) View
Insomnia NON_SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (17.1) View
Polyuria NON_SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA (17.1) View
Chromaturina NON_SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA (17.1) View
Decubitus ulcer NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (17.1) View